全文获取类型
收费全文 | 4682篇 |
免费 | 253篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 82篇 |
妇产科学 | 23篇 |
基础医学 | 156篇 |
口腔科学 | 14篇 |
临床医学 | 151篇 |
内科学 | 1616篇 |
皮肤病学 | 10篇 |
神经病学 | 21篇 |
特种医学 | 138篇 |
外科学 | 2230篇 |
综合类 | 23篇 |
预防医学 | 69篇 |
眼科学 | 8篇 |
药学 | 60篇 |
中国医学 | 3篇 |
肿瘤学 | 407篇 |
出版年
2024年 | 1篇 |
2023年 | 305篇 |
2022年 | 573篇 |
2021年 | 367篇 |
2020年 | 355篇 |
2019年 | 265篇 |
2018年 | 209篇 |
2017年 | 204篇 |
2016年 | 162篇 |
2015年 | 169篇 |
2014年 | 340篇 |
2013年 | 307篇 |
2012年 | 225篇 |
2011年 | 172篇 |
2010年 | 171篇 |
2009年 | 167篇 |
2008年 | 124篇 |
2007年 | 124篇 |
2006年 | 143篇 |
2005年 | 109篇 |
2004年 | 80篇 |
2003年 | 86篇 |
2002年 | 57篇 |
2001年 | 64篇 |
2000年 | 51篇 |
1999年 | 32篇 |
1998年 | 28篇 |
1997年 | 20篇 |
1996年 | 19篇 |
1995年 | 32篇 |
1994年 | 18篇 |
1993年 | 8篇 |
1992年 | 9篇 |
1991年 | 1篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 4篇 |
1987年 | 2篇 |
1986年 | 5篇 |
1976年 | 1篇 |
排序方式: 共有5015条查询结果,搜索用时 500 毫秒
81.
82.
83.
84.
85.
《Transplantation proceedings》2021,53(7):2377-2381
BackgroundVentricular assist devices (VADs) are commonly used as a bridge to transplantation but may yield HLA sensitization. We evaluated the prevalence of HLA antibody (Ab) sampling pre- and post-VAD placement in pediatric and adult patients and notification of VAD status to the HLA laboratory.MethodsAll pediatric and adult patients who received a first-time VAD between 2005 and 2013 were included in this single-center retrospective review. Data were collected from the University of Alberta Hospital histocompatibility laboratory's information system and a local VAD database.ResultsIn total, 106 patients were included (40 pediatric, median 3.0 years [interquartile range, 0.3-10.7]; 66 adult, 55.0 years [46.8-61.2]). HLA Ab sampling within 1-month pre-VAD occurred in 70% of pediatric and 79% of adult recipients (P = .215). Testing within 1 month of VAD placement occurred in 89% of pediatric and 67% of adult recipients (P = .012). For those with HLA Ab sampling within 30 days postimplant, notification to the HLA laboratory of VAD status occurred in 19 of 27 (70%) pediatric and 24 of 33 (73%) adult patients (P = .533). Of patients transplanted post VAD with HLA Ab samples collected, 12 of 28 (43%) and 13 of 38 (34%) adult recipients did not have notification of VAD status to the HLA laboratory (P = .322).ConclusionsThere were inconsistencies in HLA Ab sampling and communication to the HLA laboratory surrounding VAD placement. Standardization of both HLA Ab assessment frequency after VAD implantation and communication regarding changes in clinical status and the occurrence of key sensitizing events such as VAD placement are imperative as patients await transplantation. 相似文献
86.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2019,21(10):1322-1326
BackgroundLiver transplantation (LT) offers patients with cirrhosis long-term survival, however many die from sepsis whilst awaiting LT. The liver's role in innate immunity may be key to improving outcomes, but the immune effects of LT have not been quantified.MethodsInnate immune capacity was assessed by clearance of 99mTc-Albumin nanospheres in patients with chronic liver failure before and after LT.ResultsTwenty-eight patients with chronic liver disease on the LT waiting list entered the study during the twelve-month study period and nine patients underwent LT and completed the study protocol. One patient developed hepatic artery thrombosis in <7 days and was excluded from the study. Innate immune function was significantly impaired in patients with chronic liver disease on the LT waiting list and this was directly correlated with MELD score. LT normalised innate immune function by day 1 post LT with further improvement occurring by day 7 post LT. Donor liver weight was the only factor correlated with innate immune function at day 1 post LT but this effect was negated by day 7 post LT.ConclusionRecognising the immune effects of LT may facilitate treatment of cirrhosis and inform development of extracorporeal liver support systems. 相似文献
87.
88.
89.
《Surgical pathology clinics》2013,6(2):277-293
Histopathologic assessment of allograft liver biopsies has an important role in managing patients who have undergone liver transplantation. In this review, several topics are discussed that create diagnostic problems in transplant pathology, with emphasis on pathologic features and differential diagnosis. The topics discussed are acute cellular rejection, late acute rejection (centrizonal/parenchymal rejection), chronic rejection, plasma cell hepatitis, idiopathic posttransplant chronic hepatitis, fibrosing cholestatic hepatitis, selected viral infections (cytomegalovirus, Epstein-Barr virus, and hepatitis E), and acute antibody-mediated rejection. 相似文献
90.